References
- American Cancer Society [homepage on the Internet]Cancer Statistics Center Available from: http://cancerstatisticscenter.cancer.orgAccessed August 7, 2018
- SharmaCEltawilKMRenfrewPDWalshMJMolinariMAdvances in diagnosis, treatment and palliation of pancreatic carcinoma: 1990–2010World J Gastroenterol201117786789721412497
- KatzMHWangHFlemingJBLong-term survival after multidisciplinary management of resected pancreatic adenocarcinomaAnn Surg Oncol200916483684719194760
- FortnerJGKlimstraDSSenieRTMacleanBJTumor size is the primary prognosticator for pancreatic cancer after regional pancreatectomyAnn Surg199622321471538597508
- RautCPTsengJFSunCCImpact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinomaAnn Surg20072461526017592291
- SchmidtCMMatosJMBentremDJTalamontiMSLillemoeKDBilimoriaKYAcinar cell carcinoma of the pancreas in the United States: prognostic factors and comparison to ductal adenocarcinomaJ Gastrointest Surg200812122078208618836784
- MckayCJGlenPMcMillanDCChronic inflammation and pancreatic cancerBest Pract Res Clin Gastroenterol2008221657318206813
- MantovaniAAllavenaPSicaABalkwillFCancer-related inflammationNature2008454720343644418650914
- GrivennikovSIGretenFRKarinMImmunityKMImmunity, inflammation, and cancerCell2010140688389920303878
- ProctorMJMorrisonDSTalwarDA comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome StudyEur J Cancer201147172633264121724383
- McMillanDCSystemic inflammation, nutritional status and survival in patients with cancerCurr Opin Clin Nutr Metab Care200912322322619318937
- ProctorMJMorrisonDSTalwarDAn inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome StudyBr J Cancer2011104472673421266974
- KasymjanovaGMacDonaldNAgulnikJSThe predictive value of pre-treatment inflammatory markers in advanced non-small-cell lung cancerCurr Oncol20101745258
- StotzMGergerAEisnerFIncreased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancerBr J Cancer2013109241642123799847
- SmithRABosonnetLRaratyMPreoperative platelet-lymphocyte ratio is an independent significant prognostic marker in resected pancreatic ductal adenocarcinomaAm J Surg2009197446647218639229
- ElinavENowarskiRThaissCAHuBJinCFlavellRAInflammation-induced cancer: crosstalk between tumours, immune cells and microorganismsNat Rev Cancer2013131175977124154716
- GencerDKästle-LarraldeNPilzLRPresentation, treatment, and analysis of prognostic factors of terminally ill patients with gastrointestinal tumorsOnkologie200932738038619556814
- SiddiquiAHeinzerlingJLivingstonEHHuertaSPredictors of early mortality in veteran patients with pancreatic cancerAm J Surg2007194336236617693283
- LeitchEFChakrabartiMCrozierJEComparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancerBr J Cancer20079791266127017923866
- CondeelisJPollardJWMacrophages: obligate partners for tumor cell migration, invasion, and metastasisCell2006124226326616439202
- HuhJWLeeJHKimHRPrognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancerArch Surg2012147436637222508783
- LiangWFerraraNThe Complex Role of Neutrophils in Tumor Angiogenesis and MetastasisCancer Immunol Res201642839126839309
- McCollSRPaquinRMénardCBeaulieuADHuman neutrophils produce high levels of the interleukin 1 receptor antagonist in response to granulocyte/macrophage colony-stimulating factor and tumor necrosis factor alphaJ Exp Med199217625935981386877
- WeitzmanSAGordonLIInflammation and cancer: role of phagocyte-generated oxidants in carcinogenesisBlood19907646556632200535
- KusumantoYHDamWAHospersGAMeijerCMulderNHPlatelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factorAngiogenesis20036428328715166496
- PillayJKampVMvan HoffenEA subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1J Clin Invest2012122132733622156198
- KohrtHENouriNNowelsKJohnsonDHolmesSLeePPProfile of immune cells in axillary lymph nodes predicts disease-free survival in breast cancerPLoS Med200529e28416124834
- BambaceNMHolmesCEThe platelet contribution to cancer progressionJ Thromb Haemost20119223724921040448
- MöhleRGreenDMooreMANachmanRLRafiiSConstitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and plateletsProc Natl Acad Sci U S A19979426636689012841
- OkamotoEOsakiMKaseSAdachiHKaibaraNItoHThymidine phosphorylase expression causes both the increase of intratumoral microvessels and decrease of apoptosis in human esophageal carcinomasPathol Int200151315816411328530
- GayLJFelding-HabermannBContribution of platelets to tumour metastasisNat Rev Cancer201111212313421258396
- LabelleMBegumSHynesRODirect signaling between platelets and cancer cells induces an epithelial-mesenchymal-like transition and promotes metastasisCancer Cell201120557659022094253
- HanahanDCoussensLMAccessories to the crime: functions of cells recruited to the tumor microenvironmentCancer Cell201221330932222439926
- GarceaGLadwaNNealCPMetcalfeMSDennisonARBerryDPPreoperative neutrophil-to-lymphocyte ratio (NLR) is associated with reduced disease-free survival following curative resection of pancreatic adenocarcinomaWorld J Surg201135486887221312035
- ClarkEJConnorSTaylorMAMadhavanKKGardenOJParksRWPreoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinomaHPB20079645646018345294
- JamiesonNBDenleySMLogueJA prospective comparison of the prognostic value of tumor- and patient-related factors in patients undergoing potentially curative surgery for pancreatic ductal adenocarcinomaAnn Surg Oncol20111882318232821267785
- SzkanderaJStotzMEisnerFExternal validation of the derived neutrophil to lymphocyte ratio as a prognostic marker on a large cohort of pancreatic cancer patientsPLoS One2013811e7822524223776
- TeoMMohd SharialMSMcDonnellFConlonKCRidgwayPFMcDermottRSPrognostic role of neutrophil-to-lymphocyte ratio in advanced pancreatic ductal adenocarcinoma: impact of baseline fluctuation and changes during chemotherapyTumori201399451652224326841
- BhattiIPeacockOLloydGLarvinMHallRIPreoperative hematologic markers as independent predictors of prognosis in resected pancreatic ductal adenocarcinoma: neutrophil-lymphocyte versus platelet-lymphocyte ratioAm J Surg2010200219720320122680
- WangDSLuoHYQiuMZComparison of the prognostic values of various inflammation based factors in patients with pancreatic cancerMed Oncol20122953092310022476808
- AliustaogluMBiliciASekerMThe association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancerHepatogastroenterology20105799–10064064520698242
- AsaokaTMiyamotoAMaedaSPrognostic impact of preoperative NLR and CA19-9 in pancreatic cancerPancreatology201616343444026852169
- IasonosASchragDRajGVPanageasKSHow to build and interpret a nomogram for cancer prognosisJ Clin Oncol20082681364137018323559